Gynecologic Pathology Diagnostic Services
The Gynecologic Pathology Diagnostic Service is a fundamental component in the prevention, diagnosis and treatment of diseases of the female genital organs at Yale-New Haven Hospital and Smilow Cancer Hospital. Our pathologists are subspecialty-trained and highly experienced with a passion for patient care. Our service encounters a high volume of complex, neoplastic gynecologic surgical specimens from the Yale Gynecologic Oncology Service and biopsy specimens from many outpatient clinics in the greater New Haven area. Beyond routine tissue diagnosis, team members actively participate in the real-time decision making process for patient management including daily intraoperative consultation, weekly Gynecologic Tumor Conferences and many on-going cancer clinical trial programs. Currently, two faculty members function as the center pathologists in the study design and patient selection for the Herceptin trial program, a multi-institutional effort led by Yale Gynecologic Oncology Service in search for alternative therapy for endometrial serous carcinoma. For consultation diagnostic services, we provide diagnostic expertise for pathologists throughout the United States and abroad who submit cases for second opinion. The Gynecologic Pathology Service also reviews a large number of specimens from patients who are referred to Yale for further treatment options. As a leading institution, we have a national and international reputation as experts in the diagnosis of gestational trophoblastic diseases (complete and partial hydatidiform moles, gestational trophoblastic tumors) and endometrial cancer. We are among the few institutions to offer molecular genotyping as part of the routine diagnostic algorithm for molar pregnancies.
Professor of Pathology and of Obstetrics, Gynecology and Reproductive Sciences
Director, Gynecologic Pathology
Clinical Director, Molecular Diagnostics Laboratory
Director, Gynecologic and Breast Pathology Fellowship Program.
Ovarian Neoplasms; Pathology, Surgical
Dr. Hui is Professor in the Department of Pathology and Department of Obstetrics, Gynecology and Reproductive Sciences at Yale School of Medicine. He received combined anatomic and clinical pathology residency training at Yale-New Haven Hospital in 2000, followed by Oncological Pathology Fellowship training at MSKCC. He joined the pathology faculty at Yale in 2001 and became full professor in 2013. Dr. Hui is a board certified surgical pathologist with clinical specialty areas including...
Dr. Abi Raad received her MD from Universite Saint Joseph in Lebanon in 1994. She completed her residency in Anatomic and Clinical pathology and a fellowship in cytopathology at Yale-New Haven Hospital. Dr. Abi Raad is board certified in Clinical and Anatomic Pathology, and Cytopathology.
Associate Professor of Pathology
Associate Director of Gynecologic Pathology
Carcinoma, Endometrioid; Cervical Intraepithelial Neoplasia; Choriocarcinoma, Non-gestational; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrial Stromal Tumors; Endometriosis; Endometritis; Gestational Trophoblastic Disease; Hereditary Breast and Ovarian Cancer Syndrome; Ovarian Cysts; Ovarian Diseases; Ovarian Neoplasms; Ovary; Pathology Department, Hospital; Pathology, Surgical; Sarcoma, Endometrial Stromal; Uterine Cervical Diseases; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Diseases; Vulvar Neoplasms
Dr. Buza specializes in breast and gynecological pathology. She has been part of the Yale Pathology Breast and GYN team since 2010.
Professor of Pathology
Director, Genitourinary Pathology
Peter A. Humphrey, M.D., Ph.D. obtained his B.A. in Chemistry and Biochemistry, and his MD and PhD (in biochemistry) from The University of Kansas. He did his anatomic pathology residency at Duke University Medical Center, and joined the faculty there for four years, followed by 21 years as a faculty member at Washington University School of Medicine. Dr. Humphrey is a practicing surgical and urologic pathologist, with a research focus on clinico-pathologic and molecular pathologic aspects...